| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00848260 |
| P698 | PubMed publication ID | 3172187 |
| P2093 | author name string | D R Nerenz | |
| D V Easterling | |||
| H Leventhal | |||
| R R Love | |||
| P2860 | cites work | Behavioral regulation of the milieu interne in man and rat | Q28215176 |
| Dose-response effect of adjuvant chemotherapy in breast cancer | Q28283048 | ||
| Psychosocial consequences of cancer chemotherapy for elderly patients | Q33723002 | ||
| Conditioning of drug-induced physiological responses. | Q34280700 | ||
| Factors that influence postoperative vomiting | Q35451724 | ||
| Conditioned aversive responses in cancer chemotherapy patients: theoretical and developmental analysis | Q39746096 | ||
| Anticipatory nausea and vomiting in pediatric cancer patients | Q41389142 | ||
| Personality factors associated with anticipatory nausea/vomiting in patients receiving cancer chemotherapy | Q41395281 | ||
| Susceptibility to motion sickness and the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy | Q48629928 | ||
| Anticipatory nausea and emotional distress in patients receiving cisplatin-based chemotherapy. | Q51199502 | ||
| Anxiety and drug taste as predictors of anticipatory nausea in cancer chemotherapy. | Q51213416 | ||
| Development of anticipatory nausea: a prospective analysis. | Q52266102 | ||
| Clinical characteristics associated with the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy treatment. | Q52272407 | ||
| Behavioral intervention in cancer treatment: controlling aversion reactions to chemotherapy. | Q52285097 | ||
| Prevalence of anticipatory nausea and emesis in cancer chemotherapy patients. | Q52285218 | ||
| Factors contributing to emotional distress during cancer chemotherapy. | Q52286635 | ||
| Pretreatment nausea in cancer chemotherapy: a conditioned response? | Q52300543 | ||
| The existential plight in cancer: significance of the first 100 days | Q66837852 | ||
| Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo | Q66978560 | ||
| The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy | Q70105967 | ||
| Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma | Q70252464 | ||
| Anticipatory nausea and vomiting in an ambulatory medical oncology population | Q71139618 | ||
| Behavioral Treatment for the Anticipatory Nausea and Vomiting Induced by Cancer Chemotherapy | Q72540281 | ||
| P433 | issue | 2 | |
| P921 | main subject | motion sickness | Q309067 |
| P304 | page(s) | 117-130 | |
| P577 | publication date | 1988-04-01 | |
| P1433 | published in | Journal of Behavioral Medicine | Q6294833 |
| P1476 | title | The role of motion sickness in predicting anticipatory nausea. | |
| P478 | volume | 11 |
| Q51093955 | Changes in heart rate and respiration rate in patients with vestibular dysfunction following head movements which provoke dizziness. |
| Q34470590 | Ginger-Mechanism of action in chemotherapy-induced nausea and vomiting: A review |
| Q40638217 | Life experience of Taiwanese adolescents with cancer |
| Q37470397 | Olfactory-triggered panic attacks among Khmer refugees: a contextual approach |
| Q34460077 | Panic disorder among Vietnamese refugees attending a psychiatric clinic: prevalence and subtypes |
| Q47430125 | Panic disorder, somatization, and the new cross-cultural psychiatry: the seven bodies of a medical anthropology of panic |
| Q36095132 | Prevalence of Delayed Nausea and/or Vomiting in Patients Treated With Oxaliplatin-Based Regimens for Colorectal Cancer |
| Q51055759 | Prevalence of anticipatory nausea and other side-effects in cancer patients receiving chemotherapy. |
| Q36296466 | Psychological techniques for controlling the adverse side effects of cancer chemotherapy: Findings from a decade of research |
| Q35976157 | The control of acute cisplatin-induced emesis--a comparative study of granisetron and a combination regimen of high-dose metoclopramide and dexamethasone. Granisetron Study Group |
Search more.